{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intermediate+dose&page=30", "query": { "intervention": "Intermediate dose", "page": 30 }, "page_size": 10 }, "pagination": { "page": 30, "page_size": 10, "total_count": 2634, "total_pages": 264, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intermediate+dose&page=31&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intermediate+dose&page=29&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-27T19:43:43.461Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00002665", "title": "SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Leukemia", "Neutropenia", "Thrombocytopenia" ], "interventions": [ { "name": "asparaginase", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cytarabine", "type": "DRUG" }, { "name": "daunorubicin hydrochloride", "type": "DRUG" }, { "name": "dexamethasone", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "leucovorin calcium", "type": "DRUG" }, { "name": "mercaptopurine", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" }, { "name": "prednisone", "type": "DRUG" }, { "name": "thioguanine", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "allogeneic bone marrow transplantation", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "15 Years to 65 Years" }, "enrollment_count": 50, "start_date": "1995-07", "completion_date": "2003-12", "has_results": false, "last_update_posted_date": "2015-03-06", "last_synced_at": "2026-10-27T19:43:43.461Z", "location_count": 83, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 54 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002665" }, { "nct_id": "NCT04427228", "title": "Single vs Multi-fraction SRS Patients on Immunotherapy", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Brain Cancer", "Brain Metastases" ], "interventions": [ { "name": "Radiosurgery Single Treatment", "type": "RADIATION" }, { "name": "Radiosurgery Three Treatments", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2020-06-29", "completion_date": "2022-12-12", "has_results": false, "last_update_posted_date": "2023-08-28", "last_synced_at": "2026-10-27T19:43:43.461Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04427228" }, { "nct_id": "NCT04225299", "title": "Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Localized Prostate Cancer" ], "interventions": [ { "name": "TOOKAD®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Steba Biotech S.A.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 0, "start_date": "2020-03-31", "completion_date": "2030-07-01", "has_results": false, "last_update_posted_date": "2020-11-13", "last_synced_at": "2026-10-27T19:43:43.461Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04225299" }, { "nct_id": "NCT04484532", "title": "Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Acute Myeloid Leukemia", "Myelodysplastic Syndrome" ], "interventions": [ { "name": "Trivalent Influenza Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Roswell Park Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 130, "start_date": "2017-10-17", "completion_date": "2022-06-07", "has_results": false, "last_update_posted_date": "2023-06-06", "last_synced_at": "2026-10-27T19:43:43.461Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04484532" }, { "nct_id": "NCT02920398", "title": "A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Congenital Bleeding Disorder", "Haemophilia A" ], "interventions": [ { "name": "turoctocog alfa pegol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "MALE", "summary": "12 Years and older · Male only" }, "enrollment_count": 21, "start_date": "2016-10-04", "completion_date": "2017-04-07", "has_results": false, "last_update_posted_date": "2017-12-15", "last_synced_at": "2026-10-27T19:43:43.461Z", "location_count": 5, "location_summary": "Torrance, California • Iowa City, Iowa • Baltimore, Maryland + 2 more", "locations": [ { "city": "Torrance", "state": "California" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Dayton", "state": "Ohio" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02920398" }, { "nct_id": "NCT04709081", "title": "A Drug Interaction Study of ACH-0145228", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "ACH-0145228", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Digoxin", "type": "DRUG" }, { "name": "Itraconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 38, "start_date": "2019-12-22", "completion_date": "2020-04-16", "has_results": false, "last_update_posted_date": "2021-01-14", "last_synced_at": "2026-10-27T19:43:43.461Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04709081" }, { "nct_id": "NCT01196871", "title": "Drug-Drug Interaction Study Between AT1001 (Migalastat Hydrochloride) and Agalsidase in Participants With Fabry Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fabry Disease" ], "interventions": [ { "name": "Migalastat HCl", "type": "DRUG" }, { "name": "Agalsidase Beta", "type": "BIOLOGICAL" }, { "name": "Agalsidase Alfa", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Amicus Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "18 Years to 65 Years · Male only" }, "enrollment_count": 20, "start_date": "2011-02-02", "completion_date": "2012-10-09", "has_results": true, "last_update_posted_date": "2018-12-19", "last_synced_at": "2026-10-27T19:43:43.461Z", "location_count": 5, "location_summary": "Birmingham, Alabama • Decatur, Georgia • Iowa City, Iowa + 2 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Decatur", "state": "Georgia" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Springfield", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01196871" }, { "nct_id": "NCT03990363", "title": "A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Kidney Disease" ], "interventions": [ { "name": "Verinurad", "type": "DRUG" }, { "name": "Allopurinol", "type": "DRUG" }, { "name": "Placebo for Verinurad", "type": "DRUG" }, { "name": "Placebo for Allopurinol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 861, "start_date": "2019-07-23", "completion_date": "2021-11-22", "has_results": true, "last_update_posted_date": "2023-03-02", "last_synced_at": "2026-10-27T19:43:43.461Z", "location_count": 54, "location_summary": "Huntsville, Alabama • Bakersfield, California • Canyon Country, California + 45 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Bakersfield", "state": "California" }, { "city": "Canyon Country", "state": "California" }, { "city": "Laguna Hills", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03990363" }, { "nct_id": "NCT07792616", "title": "Electrical Neuromodulation for Modifying Spinal Network Involved in Spasticity", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spinal Cord Injuries (Complete and Incomplete)", "Spinal Cord Injury", "Spinal Cord Injury Cervical", "Spinal Cord Injury Thoracic", "Spinal Cord Injuries", "Spasticity", "Spasm", "Muscle Spasticity", "Muscle Hypertonia", "Muscle Spasm" ], "interventions": [ { "name": "Transcutaneous spinal stimulation at 30 Hz", "type": "OTHER" }, { "name": "Transcutaneous spinal stimulation at 75 Hz", "type": "OTHER" }, { "name": "Tizanidine", "type": "DRUG" }, { "name": "Baclofen", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "University of Mississippi Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2022-07-13", "completion_date": "2027-07-14", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-10-27T19:43:43.461Z", "location_count": 2, "location_summary": "Jackson, Mississippi", "locations": [ { "city": "Jackson", "state": "Mississippi" }, { "city": "Jackson", "state": "Mississippi" } ], "official_url": "https://clinicaltrials.gov/study/NCT07792616" }, { "nct_id": "NCT03878316", "title": "Intranasal Oxytocin for the Treatment of Alcohol Use Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alcohol Use Disorder", "Alcohol Misuse" ], "interventions": [ { "name": "Instranasal Oxytocin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute on Alcohol Abuse and Alcoholism (NIAAA)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2022-06-29", "completion_date": "2023-10-13", "has_results": true, "last_update_posted_date": "2025-08-07", "last_synced_at": "2026-10-27T19:43:43.461Z", "location_count": 4, "location_summary": "Los Angeles, California • Baltimore, Maryland • Boston, Massachusetts + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03878316" } ] }